Warfant 5 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfant 5 mg tablets

mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 5 milligram(s) - vitamin k antagonists; warfarin

Warfant 3 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfant 3 mg tablets

mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 3 milligram(s) - vitamin k antagonists; warfarin

Warfarin Rosemont 1 mg/1 ml Oral Suspension आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin rosemont 1 mg/1 ml oral suspension

rosemont pharmaceuticals ltd - warfarin sodium - oral suspension - 1 milligram(s)/millilitre - vitamin k antagonists; warfarin

ZEPHOLIN S.R. 200 Milligram Prolonged Release Capsules आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

zepholin s.r. 200 milligram prolonged release capsules

astellas pharma co. ltd - theophylline - prolonged release capsules - 200 milligram - xanthines

ZEPHOLIN S.R. 100 Milligram Prolonged Release Capsules आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

zepholin s.r. 100 milligram prolonged release capsules

astellas pharma co. ltd - theophylline - prolonged release capsules - 100 milligram - xanthines

ZEPHOLIN S.R. 350 Milligram Prolonged Release Capsules आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

zepholin s.r. 350 milligram prolonged release capsules

astellas pharma co. ltd - theophylline - prolonged release capsules - 350 milligram - xanthines

Warfarin Teva 0.5mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 0.5mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 0.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extensiona and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 1 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 1 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 1 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 2 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 2 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 2.5 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 2.5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.